Medical/Pharmaceuticals
VISTA Eye Specialist Won Four (4) Prestigious Awards in 2021
PETALING JAYA, Malaysia, March 24, 2022 /PRNewswire/ -- VISTA Eye Specialist
(VISTA), one of leading eye specialists inMalaysia established since 1999, has
recently won the Golden Bull 2021 Outstanding SME Award to round off an
eventful year.
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
Huma acquires AstraZeneca's digital health platform AMAZE™ and AstraZeneca
becomes a shareholder of Huma
LONDON and NEW YORK, March 23, 2022 /PRNewswire/ -- Huma Therapeutics Limited
LIMACORPORATE INTRODUCES L.E.A.R.N. THE NEW PLATFORM FOR A UNIQUE MEDICAL EDUCATION EXPERIENCE
UDINE, Italy, March 24, 2022 /PRNewswire/ -- Limacorporate S.p.A., leading global orthopedic manufacturer, is proud to introduce L.E.A.R.N. - LimaCorporate's Education and Resource Network. L.E.A.R.N. is a new and unique medical education experience, platform and network supporting surgeons in r...
Fosun International Announces 2021 Annual Results: Total Revenue Increased by 18% to RMB161.29 Billion, Striving to Pursue Steady and Sustainable Development
2021 Annual Results Summary and Highlights: * Total operating revenue for the year amounted to RMB161.29 billion, representing a year-on-year increase of 18%; profit attributable to owners of the parent reachedRMB10.09 billion, representing a year-on-year increase of 26%; * Profit of industria...
CARsgen Announces First Patient Enrollment in the Confirmatory Phase II Clinical Trial of CT041 in China
SHANGHAI, March 23, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors, today announced that CT041, an autologous CAR T-cell product candidate against...
CARsgen 2021 Annual Results: Steady Advancement in Innovative CAR T Products and Technologies
SHANGHAI, March 23, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2021 Annual Results. Business Highlights * CT053: complete...
Smartee Raises US$ 80 Million in Series D Funding
BEIJING, March 23, 2022 /PRNewswire/ -- In March 2022, Smartee announced that it has closed its Series D funding round ofUS$ 80 million. This round of financing was led by Beijing Taikang Investment, followed by China Resources Consumer Fund II, Jiaxing Science City, Zhangjiagang Industrial Inves...
Clarivate Patient Centricity Report Underscores Need for Evolution from Selling Products to Building Relationships
LONDON, March 23, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report,Walking the talk on patient centricity: An actionable and measurable model for life sc...
Telix Advances Development of Glioblastoma Therapy Program
MELBOURNE, Australia, March 23, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces it has made significant progress in advancing the Company's glioblastoma multiforme (GBM) therapy candidate TLX101 into the next stage of clinical development. TLX101 (4-L-...
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India
* First authorization of Novavax' COVID-19 vaccine in adolescent population received * Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorizedfor adolescents ≥12 to <18 inIndia * Authorization highligh...
Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA
HELSINKI, Finland, March 23, 2022 /PRNewswire/ -- Inside information Nanoform Finland Plc March 22, 2022 23:45 Finnish time / 22:45 Swedish time Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in theUSA NOT FOR RELEASE, PUBLICATION OR D...
InnoCare Releases 2021 Annual Results and Business Highlights
BEIJING, March 22, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2021 annual results as of31 December 2021. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, "We are delighted ...
VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease
SHANGHAI, March 22, 2022 /PRNewswire/ -- VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of innovative therapies for ocular diseases, today announced positive topline results from a Phase 2 clinical study of VVN001 in patients wi...
Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results
– Advancing key programs in HBV, CNS, and HIV – – Received first BLA approval for COVID-19 Treatment in China and added to China's latest COVID-19 Diagnosis and Treatment Guidelines– – Multiple clinical value drivers expected across the portfolio in 2022 and beyond – – Cash, bank balances, an...
Arum Therapeutics implements CDD Vault to streamline its research data and collaboration workflows.
SEOUL, South Korea and BURLINGAME, Calif., March 23, 2022 /PRNewswire/ -- Arum Therapeutics Inc. (Arum), a leading pharmaceutical company that specializes in the discovery of new molecules and molecule combinations to target novel oncology announced today that it had implementedCDD Vault, a resea...
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively
The Proportion of Revenue from Innovative Products Continues to Increase Highlights: * Revenue for the year ended December 31, 2021 was RMB39,005 million, representing an increase of 28.70% YOY; * The proportion of revenue from new products as well as regions outside Mainland China and count...
Servatus launches Australia's first human study into the effects of live biotherapeutics on insomnia
* Study to look at the link between the gut microbiome and sleep, by treating patients who suffer from insomnia with live biotherapeutics * Phase I/II trial will run during 2022, with results expected in 2023 * Close to 15% of the Australian population suffer from insomnia, with sleep disord...
WuXi Biologics Achieved Record Growth and Profitability in 2021
Banner Year for Commercial Manufacturing Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million Gross Profit Increased by 90.6% Y-o-Y to RMB4,828.9 Million Net Profit Grew by 107.3% Y-o-Y to RMB3,508.6 Million Adjusted Net Profit Rose by 100.3% to RMB3,435.9 Million Total Backlog Grew 20.1% to ...
INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use
GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ -- PHASE
Scientific International, LTD
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83%
BEIJING and SHANGHAI and BOSTON, March 22, 2022 /PRNewswire/ -- Jacobio Announced its 2021 annual results on 22 March. As a clinical-stage biotech company, Jacobio's revenue wasRMB152 million, which was generated from an out-licensing deal. Its R&D investment wasRMB421 million, showing an increas...
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31